Appendix B: Panel Roster and Financial Disclosures
Toxoplasma gondii
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
Sarita Boyd | U.S. Food and Drug Administration | None | N/A |
Joseph Kovacs* | National Institutes of Health |
Martinas BioPharma Merck |
Research Support (paid to institution) |
Janaki Kuruppu | National Institutes of Health | None | N/A |
Leon Lai | MedStar Washington Hospital Center | None | N/A |
Jose M. Miro | Hospital Clinic-IDIBAPS, University of Barcelona, Spain | None | N/A |
Daniel Podzamczer | Fight AIDS and Infectious Disease Foundation, Hospital Germans Trias i Pujol, Badalona, Spain |
Janssen ViiV Healthcare |
Consultant |
Gilead Sciences MSD |
Research Support (paid to institution) | ||
Bryan R. Smith | National Institutes of Health | None | N/A |
* Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Section Only PDF (31.54 KB)
- Full Guideline PDF (6.03 MB)
- Tables Only PDF (1.18 MB)